Arvinas Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include Lyell and Elicio Therapeutics.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ |
Employees | Employees 85 | Employees 188 | Employees 22 |
Valuation ($) | Valuation ($) 272.5 m | Valuation ($) 391.6 m | Valuation ($) N/A |
Employee Rating | Employee Rating 4.2 | Employee Rating 3.4 | Employee Rating 5 |
Financial | |||
Revenue (est.) | Revenue (est.) $19.2m (FY, 2022) | Revenue (est.) $84.7m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($112.9m) (FY, 2022) | Net income ($183.1m) (FY, 2022) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 150.3m |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company